Stock Taper
SCREENER COMPARE ANY 2 STOCKS
MBIO
MUSTANG BIO, INC.
NASDAQ
$0.54
▼ DOWN 2.27% (-0.01)

KEY STATISTICS

Market Cap$4.07 M
52w High$1.85
52w Low$0.53
Dividend Yield—
Frequency—
P/E-1.19
Volume20.24K
Shares Out.7.58M

COMPANY

LEADERSHIP

Manuel Litchman
CHIEF EXECUTIVE
Manuel Litchman

COMPENSATION 2026

Salary$485,500
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$12,542
Total$498,042

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 22, 2017
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
4

UPCOMING EARNINGS

DateNov 18, 2026
DayWednesday
Rev. Est.—
NOV
18
WED

SPLIT RECORD

DATETYPERATIO
2025-01-16Reverse1:50
2023-04-04Reverse1:15

PRICE

$0.54 ▼ DOWN 2.27% (−$0.01)
OVERLAYS
$0.54$0.54$0.55$0.559:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.54

About Mustang Bio, Inc.

https://www.mustangbio.com ↗

Mustang Bio, Inc. is a clinical-stage biopharma company developing gene and CAR T therapies for hematologic cancers, solid tumors, and rare genetic diseases, with partnerships and a diverse pipeline including treatments for immune deficiencies and...

INDUSTRY

Biotechnology

A PRODUCT MUSTANG BIO, INC. IS KNOWN FOR

MB-106
MB-106

MB-106 is Mustang Bio’s leading CD20-targeted CAR T-cell therapy in Phase 1/2 trials for hematologic cancers like Waldenstrom macroglobulinemia and follicular lymphoma, demonstrating promising safety and efficacy.

COMPETITORS

COMPETITOR
AUTL COMPARE
BMY COMPARE
GILD COMPARE
JNJ COMPARE
NVS COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
2
LISTED HERE
2
RANKED BY POSITION SIZE
VXF
0.00% · 25.7K
PQ
PQSG
0.20% · 8.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
14.27%
HOLDERS
30
TOP 12 OF 30 · RANKED BY POSITION SIZE
Telemetry Investments, L.L.C.
392.7K sh · $155K
Kestra Advisory Services, LLC
176.0K sh · $128.16K
Geode Capital Management, LLC
92.8K sh · $67.55K
Blackrock Inc.
87.2K sh · $41.25K
Citadel Advisors LLC
84.8K sh · $83.15K
Blackrock, Inc.
84.7K sh · $61.7K
Two Sigma Investments, LP
40.0K sh · $39.27K
Tiaa Cref Investment Management LLC
36.4K sh · $124K
Xtx Topco Ltd
24.1K sh · $23.62K
Urban Wealth Management, LLC
22.0K sh · $13K
Cfo4life Group, LLC
20.5K sh · $14.9K
Teachers Advisors, LLC
20.3K sh · $69K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
DIRECTOR, OFFICER: PRESIDENT, CEO AND INTERIM CFO
Litchman Manuel MD
Sale · 19 shares
2026-04-24
★
10 PERCENT OWNER
Fortress Biotech, Inc.
Purchase · 278.4K shares
2026-01-02
★
DIRECTOR
Herskowitz Neil
Sale · 247 shares
2025-12-30
★
DIRECTOR
Chill Adam J.
Sale · 4 shares
2025-12-30

SECTORS PEERS

PEERPRICE
DWTX$2.65COMPARE
MRKR$1.37COMPARE
TRAW$0.59COMPARE
IMRN$1.15COMPARE
BOLT$3.81COMPARE
ACXP$1.44COMPARE
EVGN$0.55COMPARE
RNAZ$2.18COMPARE